|
|
|
|
| Join Bioprocess Online Live on October 7 at 11am ET for an interactive discussion on evolving CMC strategies for ADCs with leading experts in the space. This Q&A will feature CrossBridge Bio’s CEO and co-founder, Michael Torres, Ph.D., and acting CTO, Morris Rosenberg, Ph.D., as well as Borys Shor, Ph.D., an advisor to OS Therapies and director at Manhattan BioSolutions. Registration is free for this digital event thanks to Cytiva. |
|
|
|
|
By GlobalData | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. | |
|
|
| How CMOS/CDMOS Drive Industry Growth | Article | By Tristan Passeggiati, Asahi Kasei Bioprocess | From minimizing costs and accessing advanced tech to speeding market entry, dive into how outsourcing drug development and manufacturing to CMOs/CDMOs offers strategic advantages. |
|
|
| Quantifying Cell Response With Duplex RT-qPCR | Webinar | Catalent | Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays. |
|
|
|
|
|
|
|
|
|
| AAPS PharmSci 360 delivers research spanning the pharmaceutical pipeline, from discovery to manufacturing to delivery. Thousands of scientists and decision-makers from across the globe converge to discuss cutting-edge breakthroughs, technologies, and techniques at this science-first event. Join your colleagues for the latest in pharmaceutical science in San Antonio, Texas, November 9-12, 2025. Register today! |
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development. Gain insights across cell culture, therapy development, and CGT manufacturing, and learn from world-renowned leaders Bobby Gaspar (Orchard Therapeutics), Christof Von Kalle, (Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Bioprocess Online: |
|
|
|
